$AIFF
FIREFLY NEUROSCIENCE, INC. Stock $aiff

$aiff Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921012542 Filed on May 17, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q1
Revenue	$3.420M	$3.100M	$2.062M
YoY Change	65.86%	47.62%	74.9%
Cost Of Revenue	$2.400M	$2.170M	$1.783M
YoY Change	34.61%	23.3%	108.29%
Gross Profit	$1.020M	$930.0K	$278.8K
YoY Change	265.69%	173.53%	-13.63%
Gross Profit Margin	29.82%	30.0%	13.52%
Selling, General & Admin	$680.3K	$570.0K	$340.8K
YoY Change	99.6%	18.75%	-29.79%
% of Gross Profit	66.71%	61.29%	122.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.383K	$3.180K	$1.248K
YoY Change	331.33%	-68.2%	-8.64%
% of Gross Profit	0.53%	0.34%	0.45%
Operating Expenses	$680.3K	$570.0K	$340.8K
YoY Change	99.6%	18.75%	-29.79%
Operating Profit	$268.9K	$360.0K	-$127.6K
YoY Change	-310.7%	-357.14%	-34.07%
Interest Expense	$1.459K
YoY Change
% of Operating Profit	0.54%
Other Income/Expense, Net	$3.404K	$0.00	$1.268K
YoY Change	168.45%
Pretax Income	$270.8K	$360.0K	-$126.3K
YoY Change	-314.36%	-357.14%	-33.8%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$270.8K	$360.0K	-$126.3K
YoY Change	-314.36%	-357.14%	-33.8%
Net Earnings / Revenue	7.92%	11.61%	-6.13%
Basic Earnings Per Share	$0.02		-$0.01
Diluted Earnings Per Share	$0.02	$28.19K	-$0.01
COMMON SHARES
Basic Shares Outstanding	11.28M		11.21M
Diluted Shares Outstanding	12.29M		11.21M

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.016M	$1.860M	$750.0K
YoY Change	302.13%	78.85%	-58.33%
Cash & Equivalents	$3.016M	$1.858M	$751.0K
Short-Term Investments
Other Short-Term Assets	$106.3K	$4.790K	$290.0K
YoY Change	-63.35%	53.53%	45.0%
Inventory
Prepaid Expenses		$142.8K
Receivables	$1.186M	$1.442M	$594.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.308M	$3.443M	$1.637M
YoY Change	163.11%	55.92%	-40.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$61.40K	$62.17K	$8.433K
YoY Change	628.03%	542.14%	-96.33%
Goodwill		$0.00
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets		$6.281K	$6.281K
YoY Change		0.0%	-37.19%
Total Long-Term Assets	$429.9K	$330.5K	$140.4K
YoY Change	206.2%	99.45%	-38.95%
TOTAL ASSETS
Total Short-Term Assets	$4.308M	$3.443M	$1.637M
Total Long-Term Assets	$429.9K	$330.5K	$140.4K
Total Assets	$4.738M	$3.774M	$1.778M
YoY Change	166.51%	58.96%	-40.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$192.2K	$103.6K	$24.35K
YoY Change	689.44%	-52.07%	-90.64%
Accrued Expenses	$452.2K	$480.0K	$330.0K
YoY Change	37.02%	26.32%	-10.81%
Deferred Revenue	$455.5K	$946.9K	$270.8K
YoY Change	68.21%	103.97%
Short-Term Debt	$500.0K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$149.0K	$93.01K
YoY Change
Total Short-Term Liabilities	$2.026M	$1.803M	$723.0K
YoY Change	180.18%	54.65%	-39.24%
LONG-TERM LIABILITIES
Long-Term Debt	$301.0K	$357.0K	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$20.00K
YoY Change		-100.0%	-83.33%
Total Long-Term Liabilities	$301.0K	$357.0K	$20.00K
YoY Change	1405.0%		-83.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.026M	$1.803M	$723.0K
Total Long-Term Liabilities	$301.0K	$357.0K	$20.00K
Total Liabilities	$2.327M	$2.160M	$741.4K
YoY Change	213.84%	78.29%	-43.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.03M	-$12.31M	-$12.85M
YoY Change	-6.31%	-3.25%
Common Stock	$132.6K	$129.0K	$128.5K
YoY Change	3.16%	0.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$930.2K	$930.2K	$930.2K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$1.643M	$1.643M	$1.643M
Shareholders Equity	$2.411M	$1.613M	$1.036M
YoY Change
Total Liabilities & Shareholders Equity	$4.738M	$3.774M	$1.778M
YoY Change	166.51%	58.96%	-40.74%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q1
OPERATING ACTIVITIES
Net Income	$270.8K	$360.0K	-$126.3K
YoY Change	-314.36%	-357.14%	-33.8%
Depreciation, Depletion And Amortization	$5.383K	$3.180K	$1.248K
YoY Change	331.33%	-68.2%	-8.64%
Cash From Operating Activities	$162.8K	$381.4K	-$288.4K
YoY Change	-156.47%	-735.72%	79.4%
INVESTING ACTIVITIES
Capital Expenditures	$4.612K	-$1.360K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$4.612K	-$1.360K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$496.0K		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$999.5K	10.00K
YoY Change
NET CHANGE
Cash From Operating Activities	$162.8K	381.4K	-288.4K
Cash From Investing Activities	-$4.612K	-1.360K
Cash From Financing Activities	$999.5K	10.00K
Net Change In Cash	$1.158M	390.1K	-288.4K
YoY Change	-501.46%	-750.12%	79.4%
FREE CASH FLOW
Cash From Operating Activities	$162.8K	$381.4K	-$288.4K
Capital Expenditures	$4.612K	-$1.360K
Free Cash Flow	$158.2K	$382.8K	-$288.4K
YoY Change	-154.87%	-737.98%	79.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000803578
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12045690
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	INFORMATION ANALYSIS INC
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	iaic	Contract With Customer Asset Contract Assets Added ContractWithCustomerAssetContractAssetsAdded	131943
CY2021Q1	iaic	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	93934
CY2020Q1	iaic	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	19136
CY2021Q1	iaic	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	585322
CY2020Q1	iaic	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	212568
CY2020Q4	iaic	Deferred Costs Of Revenue DeferredCostsOfRevenue	89068
CY2021Q1	iaic	Deferred Costs Of Revenue DeferredCostsOfRevenue	31251
CY2019Q4	iaic	Deferred Costs Of Revenue DeferredCostsOfRevenue	453607
CY2020Q1	iaic	Deferred Costs Of Revenue DeferredCostsOfRevenue	246351
CY2021Q1	iaic	Deferred Costs Of Revenue Added DeferredCostsOfRevenueAdded	17406
CY2020Q1	iaic	Deferred Costs Of Revenue Added DeferredCostsOfRevenueAdded	181
CY2021Q1	iaic	Deferred Costs Of Revenue Expense DeferredCostsOfRevenueExpense	75223
CY2020Q1	iaic	Deferred Costs Of Revenue Expense DeferredCostsOfRevenueExpense	207437
CY2021Q1	iaic	Number Of Subcontracts With Significant Financing Component NumberOfSubcontractsWithSignificantFinancingComponent	1
CY2021Q1	iaic	Subcontract Payments Receivable Deferred Until Specific Deliverable Is Met Percent SubcontractPaymentsReceivableDeferredUntilSpecificDeliverableIsMetPercent	0.1
CY2021Q1	iaic	Subcontract Payments Receivable Interest Rate SubcontractPaymentsReceivableInterestRate	0.045
CY2021Q1	iaic	Subcontract Payments Receivable Under Regular Terms Percent SubcontractPaymentsReceivableUnderRegularTermsPercent	0.9
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	751046
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1157783
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-288396
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1185963
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	192213
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	103646
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1442231
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1185963
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1442231
CY2021Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	276794
CY2020Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	181626
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	317703
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	312320
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15243769
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14720065
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27711
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	450
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27711
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	450
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021Q1	us-gaap	Assets Assets	4738137
CY2020Q4	us-gaap	Assets Assets	3773701
CY2021Q1	us-gaap	Assets Current AssetsCurrent	4308200
CY2020Q4	us-gaap	Assets Current AssetsCurrent	3443161
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	70530
CY2020Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3015943
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1858160
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1858160
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1039442
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3015943
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P180D
CY2021Q1	us-gaap	Gross Profit GrossProfit	1019650
CY2020Q1	us-gaap	Gross Profit GrossProfit	278827
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	270815
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-126339
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13260042
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12904376
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11617426
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11261760
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	132599
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	129043
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	270815
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-126339
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	210688
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	342631
CY2021Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	342631
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	210688
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	946884
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	455496
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	464223
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	270791
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	455496
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	946884
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	492494
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	212568
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	2399930
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	1782929
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5383
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1248
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	421183
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	375168
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	301242
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-191879
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-256268
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-73787
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-25986
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-51152
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	131943
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	88567
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-491388
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-193432
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-31775
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-36476
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-208699
CY2021Q1	us-gaap	Increase Decrease In Reserve For Commissions Expense And Taxes IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes	-95168
CY2020Q1	us-gaap	Increase Decrease In Reserve For Commissions Expense And Taxes IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes	9778
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1003545
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	4583
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3125
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	18573
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	18573
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	210
CY2021Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P4Y30D
CY2021Q1	us-gaap	Liabilities Liabilities	2326679
CY2020Q4	us-gaap	Liabilities Liabilities	2160318
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4738137
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3773701
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2025680
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1803327
CY2021Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	500000
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	450000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	450000
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	149001
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	93009
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	300999
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	356991
CY2021Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	300999
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	356991
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	999549
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4612
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	162846
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-288396
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	270815
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-126339
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	270815
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-126339
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	270815
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-126339
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	149001
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	93009
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	268870
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-127607
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	26122
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	26122
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18363
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18363
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	45595
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25911
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51405
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2021Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2.70
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8047
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54274
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6281
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1945
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1268
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4612
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	106294
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	142770
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	495999
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	500000
CY2020Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3550
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61395
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62166
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12034699
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12305514
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3419580
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2061756
CY2021Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	134587
CY2020Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	65621
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	545663
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	340813
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	27711
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	450
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	129000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	145000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.87
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3585623
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1395000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1515000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1349000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1220000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.31
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.23
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.24
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1135000
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1201500
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.25
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.24
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.14
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.17
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.62
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3013473
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	235000
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	380000
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	23500
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	18500
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.36
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.94
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.17
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.15
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y150D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y330D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y30D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y300D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	5000
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.21
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25000
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	495999
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3550
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	2411458
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1613383
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1162376
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1036487
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1642616
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1642616
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	930211
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	930211
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Use of Estimates and Assumptions</div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12286216
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11211760
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11282671
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11211760

Files In Submission

Name	View Source	Status
0001437749-21-012542-index-headers.html	Edgar Link	pending
0001437749-21-012542-index.html	Edgar Link	pending
0001437749-21-012542.txt	Edgar Link	pending
0001437749-21-012542-xbrl.zip	Edgar Link	pending
ex_249458.htm	Edgar Link	pending
ex_249459.htm	Edgar Link	pending
ex_249460.htm	Edgar Link	pending
ex_249461.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
iaic-20210331.xml	Edgar Link	completed
iaic-20210331.xsd	Edgar Link	pending
iaic-20210331_cal.xml	Edgar Link	unprocessable
iaic-20210331_def.xml	Edgar Link	unprocessable
iaic-20210331_lab.xml	Edgar Link	unprocessable
iaic-20210331_pre.xml	Edgar Link	unprocessable
iaic20210331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIFF
FIREFLY NEUROSCIENCE, INC. Stock $aiff

2021 Q1 Form 10-Q Financial Statement

#000143774921012542 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIFF FIREFLY NEUROSCIENCE, INC. Stock $aiff

2021 Q1 Form 10-Q Financial Statement

#000143774921012542 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIFF
FIREFLY NEUROSCIENCE, INC. Stock $aiff